[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2002, 28(3) 166-169 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
CXC��������
����
Ƥ����
���������������
���׷�
֣��
PubMed
Article by
Article by

CXCR3����������Ƥ����

���׷�, ֣��

�㽭��ѧҽѧԺ�����ڶ�ҽԺƤ���� ���� 310009

ժҪ��

����������Ϊ���ж���������ԵĶ����ܵ�����.���Ļع���CXC������������3��������ø������յ�����10���ø������յ��Ե���ϸ�����Ӻͦø������յ���Tϸ������ѧ�������ӵĽṹ������֮���໥���á�����ѧ���ܡ�������ϸ�����źŴ���;���Լ��������̬��Ӧ��Ƥ��������м��������Ƥ�������������֯���Ĺ�ϵ.

�ؼ����� CXC��������   ����   Ƥ����  

Abstract:

Keywords:
�ո����� 2001-08-29 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Loetscher M,Gerber B,Loetscher P,et al.Chemokine receptor specific for IP10 and mig:structure,function,and expression in activated T-lymphocytes.J Exp Med,1996,184(3):963-969.
[2] Loetscher M,Loetscher P,Brass N,et al.Lymphocyte-specific chemokinereceptor CXCR3:regulation,chemokine binding and gene localization.Eur J Immtmol,1998,28(11):3696-3705.
[3] Saleedo R,Resan JH,Halverson D,et al.Differential expression and re-sponsiveness of chemokine receptors(CXCR1-3) by hmann microvascular endothelial cells and umbilical vein endothelial cells.FASEB J,2000,14(13):2055-2064.
[4] Farter JM.HuMig:a new human member of the ehemokine family of cytokines.Biochem Biophys Res Commtm,1993,192(1):223-230.
[5] Liao F,Rabin RL,Yannelli JR,et al.Human Mig chemokine:biochemical and functional characterization.J Exp Med,1995,182(5):1301-1314.
[6] Luster AD,Ravetch JV.Biochemical characterization of a gamma interfer-on-inducible cytokine(IP-10).J Exp Med,1987,166(4):1084-1097.
[7] Cole KE,Strick CA,Paradis TJ,et al.Interferon-inducible T cell alpha chemoattractant(I-TAC):a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CX-CR3.J Exp Med,1998,187(12):2009-2021.
[8] Tensen CP,Flier J,Van Der Raaij-Helmer EM,et al.Human IP-9:A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/ Mig receptor(CXCR3).J Invest Dermatol,1999,112(5):716-722.
[9] Cox MA,Jenh CH,Gonsiorek W,et al.Human interferon-inducible 10kDa protein and human interferon-inducible T cell alpha chemeattractant are allotopic tigands for human CXCR3:differential binding to receptor states.Mol Pharmacol,2001,59(4):707-715.
[10] Belporio JA,Keane MP,Arenberg DA,et al.CXC chemokines in anglo-genesis.J Leukoc Biol,2000,68(1):1-8.
[11] Romagnani P,Annunziato F,Lasagni L,et al.Cell cycle-dependent ex-pression of CXC chemokine receptor 3 by endothelial cells mediates anglostatic activity.J Clin Invest,2001,107(1):53-63.
[12] Angiolillo AL,Sgadafi C,Taub DD,et al.Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.J Exp Med,1995,182(1):155-162
[13] Bonacchi A,Romagnani P,Romanelli RG,et al.Signal transduction by the chemokine receptor CXCR3:activation of Ras/ERK,Src,and phos-phatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes.J Biol Chem,2001,276(13):9945-9954.
[14] Flier J,Boorsma DM,Bruynzeel DP,et al.The CXCR3 activating chemokines IP-10,Mig,and IP-9 are expressed in allergic hat not in irritant patch test reactions.J Invest Dermatol,1999,113(4):574-578.
[15] Smolhr BR,Luster AD,Krane JF,et al.Fixed drug eruptions:evidence for a cytokine-mediated process.J Cutan Pathol,1991,18(1):13-19.
[16] Giustizieri ML,Mascia F,Frezzolini A,et al.Keratinocytes from patients with atepie dermatitis and psoriasis show a distinct ehemokine production profde in response to T cell-derived cytokines.J Allergy Clin Immunol,2001,107(5):871-877.
[17] Gottlieb AB,Luster AID,Posnett DN,et al.Detection of a gamma inter-feron-induced protein IP-10 in psoriatic plaques.J Exp Med,1988,168(3):941-948.
[18] Rottman JB,Smith TL,Ganley KG,et al.Potential role of the chemokine receptors CXCR3,CCR4,and the integrin alphaEhata7 in the pathogene-sis of psoriasis vulgaris.Lab Invest,2001,81(3):335-347.
[19] Goebeler M,Toksoy A,Spandan U,et al.The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions.J Pathol,1998,184(1):89-95.
[20] Sgadari C,Farhar JM,AngioliUo AL,et al.Mig,the monokine induced by interferon-gamma,promotes tumor necrosis in vivo.Blood,1997,89(8):2635-2643.
[21] Kunz M,Toksoy A,Gcebeler M,et al.Strong expression of the lymphoat-tractant C-X-C ehemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma.Pathol,1999,189(4):552-558.
[22] Sarris AH,Daliani D,Ulmer R,et al.Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-celi lymphomas.Clin Cancer Res,1997,3(2):169-177.
[23] Tensen CP,Vermcer MH,van der Stoop PM,et al.Epidermal interferon-gamma inducible protein-10(IP-10) and monokine induced by gamma-in-terferon(Mig) but not IL-8 mRNA expression is associated with epider-metrepism in cutaneous T cell lymphomas.J Invest Dermatol,1998,111(2):222-226.
[24] Lu D,Duvic M,Medeiros LJ,et al.The T-cell chemokine receptor CX-CR3 is expressed highly in low-grade mycosis fungoides.Am J Clin Pathol,001,115(3):413-421.
[25] Patel DD,Zachariah JP,Whiehard LP.CXCR3 and CCR5 ligands in rheumatoid arthritis synovium.Clin Immunol,2001,98(1):39-45.
[26] Narumi S,Takenchi T,Kohayashi Y,et al.Serum levels of ifnindueible PROTEIN-10 relating to the activity of systemic lupus erythematosus.Cytokine,2000,12(10):1561-1565.
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־